Recognition and capture of breast cancer cells using an antibody-based platform in a microelectromechanical systems device.

Cancer is one of the most common diseases afflicting humans. The use of biomarkers specific for tumor cells has facilitated their identification. However, technology has not kept pace with the field of molecular biomarkers, leaving their potential unrealized. Here, we demonstrate the efficacy of recognizing and capturing cancer cells using an antibody-based, on-chip, microfluidic device. A cancer cell capture biochip consisting of microchannels of size 2.0 cm long and 500 microm wide and deep, was etched onto Polydimethylsiloxane. Epithelial membrane antigen (EMA) and Epithelial growth factor receptor (EGFR) were coated on the inner surface of the microchannels. The overall chip measured 2.0 cm x 1.5 cm x 0.5 cm. Normal and tumor breast cells in a phosphate buffered saline (PBS) suspension were flowed through the biochip channels at a rate of 15 microL/min. Breast cancer cells were preferentially captured and identified while most of normal cells passed through. The capture rates for tumor and normal cells were found to be >30% and <5%, respectively. This preliminary cancer cell capture biochip design supports our initial effort of moving a BioMEMS device, from the bench top to the clinic.

Potential role of parasitism in the evolution of mutualism in astigmatid mites: Hemisarcoptes cooremani as a model.

Phoresy is a symbiotic interaction that results in dispersal, benefiting the relocated organism without negatively impacting the phoretic host. It has long been considered that phoresy among astigmatid mites is somehow an intermediate precursor to the evolution of parasitism within the group. In astigmatid mites, only the heteromorphic deutonymph (hypopode) participates in phoretic dispersal, and the plesiomorphic hypopode may be the key to understanding the dynamics of the evolution of that parasitism. Hypopodes of Hemisarcoptes cooremani (Acari: Acariformes) and their phoretic beetle host Chilocorus cacti (Coleoptera: Coccinellidae) have become the experimental focus for studies concerned with the potential forces that influence the transition of a free-living life style into various coevolved relationships. Previous radiolabeling studies applied to H. cooremani and C. cacti determined that hypopodes of H. cooremani acquired resources from adults of C. cacti while in transit, negating the paradigm that the heteromorphy was purely phoretic. To further probe this relationship, we tested whether materials could be passed from the mites to their hosts. We report here a study using a tritium radiolabel, which indicated that beetles also acquire resources from the hypopodes. These results have implications for understanding the complex relationship between H. cooremani and C. cacti. We propose that this relationship should now correctly be defined as mutualistic (not phoretic) and develop a general model for the potential role of parasitism in the evolution of mutualism among the Astigmata.

Oxyntomodulin stimulates intestinal glucose uptake in rats.

BACKGROUND & AIMS: Enteroglucagon peptides have long been proposed as mediators of intestinal adaptation, including mucosal growth and nutrient absorptive capacity. The hypothesis that infusions of oxyntomodulin, a bioactive form of enteroglucagon, would stimulate glucose and amino acid uptake was tested and its effects were compared with those of glucagon. METHODS: Rats were infused intravenously via minipumps with either saline, rat oxyntomodulin (0.47 nmol x kg(-1) x h[-1]), or glucagon (0.88 nmol x kg(-1) x h[-1]) for 7 days, and plasma hormone levels were measured. At death, intestinal dimensions and brush border uptake of D-glucose and L-proline were measured using an in vitro everted sleeve technique. RESULTS: Plasma enteroglucagon and glucagon levels were increased 4- and 12-fold, respectively, but there were no effects on food intake, body weight, or intestinal dimensions. In contrast, oxyntomodulin and glucagon significantly stimulated total intestinal glucose uptake capacity by 44% and 53%, respectively, over controls. Oxyntomodulin most potently enhanced glucose uptake in the ileum (215%), whereas glucagon's greatest effect was in the jejunum (63%-85%). However, neither peptide affected proline uptake. CONCLUSIONS: These results support a new, specific action for oxyntomodulin in intestinal adaptation as a glucose uptake stimulator and confirm glucagon's role as a regulator of glucose uptake.

Purification and sequence of rat oxyntomodulin.

Structural information about rat enteroglucagon, intestinal peptides containing the pancreatic glucagon sequence, has been based previously on cDNA, immunologic, and chromatographic data. Our interests in testing the physiological actions of synthetic enteroglucagon peptides in rats required that we identify precisely the forms present in vivo. From knowledge of the proglucagon gene sequence, we synthesized an enteroglucagon C-terminal octapeptide common to both proposed enteroglucagon forms, glicentin and oxyntomodulin, but sharing no sequence overlap with glucagon. We then developed a radioimmunoassay using antibodies raised against the octapeptide that was specific for enteroglucagon peptides without cross-reacting with glucagon. Rat intestine was extracted, and one presumptive enteroglucagon form was purified by following the enteroglucagon C-terminal octapeptide-like immunoreactivity through several HPLC purification steps. Structural characterization of the material by amino acid composition, microsequence, and mass spectral analyses identified the peptide as rat oxyntomodulin. The 37-residue peptide consists of pancreatic glucagon plus the C-terminal extension, Lys-Arg-Asn-Arg-Asn-Asn-Ile-Ala. This now permits synthesis of an unambiguous duplicate of endogenous rat oxyntomodulin for physiological studies.

Survival of salmonids in seawater and the time-frame of growth hormone action.

In salmonids, growth hormone (GH) effectively promotes adaptation of freshwater (FW) fish to seawater (SW), but it has been unclear whether GH has osmoregulatory actions apart from those consequent to an increase in body size. Our objectives were first, to examine the minimum time and dose required for GH to enhance SW adaptation; and second, to optimize the conditions for the acute GH response in developing a convenient GH bioassay based on its plasma ion lowering effect. Trout showed markedly improved SW survival when transferred from fresh water 6, 24, or 48h after a single chum salmon GH injection (0.25 µg/g). Preadapting trout to 1/3 SW enhanced the plasma ion lowering effect of ovine GH (oGH) injected 48h before transfer of the fish to 80% SW. Endogenous plasma GH levels were elevated in control trout switched from low salinities to 80% SW but were depressed in oGH-injected fish after transfer. Under optimal test conditions (1/3 SW preadaptation, 48h pre-transfer injection, and 100% SW final challenge), the reduction in plasma Na(+), Ca(++), and Mg(++) levels of oGH-injected fish was dose-dependent. The oGH doses giving minimum and maximum responses were 50 and 200 ng/g, respectively. In short, GH exerts acute osmoregulatory actions that promote SW adaptation in the absence of changes in body size. Compared with growth GH bioassays, the osmoregulatory assay is superior in economy of time, animal costs, and hormone quantity required and potentially in specificity.

Osmoregulatory actions of growth hormone in rainbow trout (Salmo gairdneri).

The seawater-adapting actions of GH, which are independent of growth, were studied in juvenile rainbow trout (Salmo gairdneri). Hormones examined were chum salmon (Oncorhynchus keta) GH (sGH) and prolactin (sPRL), and ovine GH (oGH). Plasma Na levels of freshwater-adapted fish peaked 24 h after transfer to 67% seawater and remained high for at least 48 h. Twenty-four hours after transfer, plasma Na levels were inversely correlated to body weight. In order to limit size and growth effects in all subsequent experiments, fish having a narrow range of body weights, fed a fixed diet, and injected with hormones over a short time-period were used. Plasma Na levels 24 h after transfer to 80% seawater were reduced significantly by sGH (0.25 and 2.5 micrograms/g) and oGH (2.5 micrograms/g) compared with saline injections, whereas sPRL (2.5 micrograms/g) had no significant effect. All the GH-treated fish had lower plasma Mg levels than controls; Ca levels were significantly reduced by the high dose of sGH. Salmon prolactin had no effect on concentrations of divalent ions. When the effects of a range of doses (0.01-1.25 micrograms/g) of sGH on plasma ion levels was tested, 0.25 micrograms/g was the most potent in reducing Na and Mg levels, while 1.25 microgram/g alone reduced plasma Ca concentrations significantly. These studies show that the seawater-adapting actions of GH in trout are specific to that hormone and are not consequent to an increase in size.

Hormonal effects on L-proline transport in coho salmon (Oncorhynchus kisutch) intestine.

The hormonal control of proline transport in pyloric ceca was studied in regard to the effects of cortisol, growth hormone (GH), epinephrine, and 3-isobutyl-1-methylxanthine (IBMX). Cortisol pellets implanted in yearling freshwater (FW) salmon for 2 weeks elevated plasma cortisol levels six times above that of control fish. The maximal influx (Jmax) and the half-saturation constant (Kt) of proline influx were twofold greater in cortisol-treated fish than the values in controls; the apparent passive permeability coefficient (Pa) was significantly reduced in the former group. FW salmon implanted with GH for 2 weeks showed increased body weight gain and a higher Jmax of proline influx compared with that of control fish. GH treatment resulted in a higher Pa of proline influx as well as in a 30% increase in area-specific intestinal dry weight. Thus, GH and cortisol may play a regulatory role in intestinal amino acid absorption during salmon development. The in vitro effects of epinephrine and the phosphodiesterase inhibitor, IBMX, on short-circuit current (Isc) and proline influx in salmon intestine were examined. Epinephrine (10(-6) M) caused a rapid increase in negative Isc (mucosa, ground). Pyloric ceca preincubated with epinephrine for 30 min showed reduced total proline influx compared with influx in paired control tissues. Epinephrine increased and IBMX decreased the Kt of proline influx; IBMX also reduced Jmax. The possible interaction between the effects of epinephrine and IBMX on ion transport and Na+-coupled proline influx are discussed.